ETF Holdings Breakdown of IMCR

IMCR institutional holdings

The adjusted close for IMCR on 2025-11-12 was 35.29

The following institutional investment holdings of IMCR have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	26,477	USD 934,373	35.29
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	26,477 0.3%	USD 934,373 0.5%	35.29
Total =		52,954	USD 1,868,746

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with IMCR

Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $56.89

Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating […] - 2025-09-15 02:30:24

Immunocore (NASDAQ:IMCR) Coverage Initiated at Jefferies Financial Group

Equities research analysts at Jefferies Financial Group initiated coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “buy” rating and a $48.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 47.19% […] - 2025-08-27 02:08:52

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a […] - 2025-08-18 05:10:58

XTX Topco Ltd Decreases Stock Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR)

XTX Topco Ltd lessened its position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) by 3.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,192 shares of the company’s stock after selling 704 shares during the quarter. […] - 2025-08-07 05:00:52

Oppenheimer Asset Management Inc. Takes $225,000 Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR)

Oppenheimer Asset Management Inc. bought a new position in shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 7,574 shares of the company’s stock, valued at approximately $225,000. Several other hedge funds and other institutional investors have also modified their holdings of […] - 2025-07-01 04:50:55

GAMMA Investing LLC Increases Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)

GAMMA Investing LLC increased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 3,318.1% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 19,107 shares of the company’s stock after buying an additional 18,548 shares during the quarter. GAMMA Investing LLC’s holdings in Immunocore were worth $5,670,000 as of its […] - 2025-06-10 04:38:58

HC Wainwright Reiterates “Buy” Rating for Immunocore (NASDAQ:IMCR)

Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $100.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 158.80% from the stock’s previous close. A number of other […] - 2025-06-04 02:51:03

Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC lowered its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,954 shares of the company’s stock after selling 2,114 shares during the quarter. Squarepoint Ops LLC owned about […] - 2025-05-29 05:18:57

Deutsche Bank Aktiengesellschaft Initiates Coverage on Immunocore (NASDAQ:IMCR)

Deutsche Bank Aktiengesellschaft assumed coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $65.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 106.41% from the company’s previous close. Other […] - 2025-05-29 02:31:00

Millennium Management LLC Cuts Stake in Immunocore Holdings plc (NASDAQ:IMCR)

Millennium Management LLC reduced its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 15.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 573,362 shares of the company’s stock after selling 103,269 shares during the period. Millennium Management […] - 2025-05-22 05:01:00

BNP Paribas Financial Markets Makes New Investment in Immunocore Holdings plc (NASDAQ:IMCR)

BNP Paribas Financial Markets bought a new position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 193,115 shares of the company’s stock, valued at approximately $5,697,000. BNP Paribas Financial Markets owned 0.39% of Immunocore as […] - 2025-05-14 06:10:56

Immunocore Holdings plc (NASDAQ:IMCR) Receives $58.13 Consensus PT from Brokerages

Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to […] - 2025-05-13 02:44:54

Barclays PLC Buys 19,663 Shares of Immunocore Holdings plc (NASDAQ:IMCR)

Barclays PLC increased its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2,044.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 20,625 shares of the company’s stock after purchasing an additional 19,663 shares during the quarter. Barclays PLC’s holdings in Immunocore were […] - 2025-05-08 04:36:44

Marshall Wace LLP Lowers Stock Holdings in Immunocore Holdings plc (NASDAQ:IMCR)

Marshall Wace LLP lessened its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 85.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,610 shares of the company’s stock after selling 170,833 shares during the quarter. Marshall Wace […] - 2025-05-01 05:43:01

Immunocore Holdings plc (NASDAQ:IMCR) Stake Boosted by Geode Capital Management LLC

Geode Capital Management LLC grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned 35,492 shares of the company’s stock after acquiring an additional 420 shares during the period. Geode Capital Management LLC’s holdings in Immunocore were worth $1,047,000 as of […] - 2025-05-01 04:32:55

Renaissance Technologies LLC Sells 179,630 Shares of Immunocore Holdings plc (NASDAQ:IMCR)

Renaissance Technologies LLC decreased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 65.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,570 shares of the company’s stock after selling 179,630 shares during the period. Renaissance Technologies LLC owned […] - 2025-04-25 05:17:01

Brokerages Set Immunocore Holdings plc (NASDAQ:IMCR) Price Target at $63.73

Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have issued a buy recommendation on the company. […] - 2025-04-18 02:28:59

Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Orion Portfolio Solutions LLC

Orion Portfolio Solutions LLC lessened its position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 37.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,017 shares of the company’s stock after selling 7,675 shares during the period. Orion Portfolio […] - 2025-04-09 05:02:51

Financial Contrast: Immunocore (NASDAQ:IMCR) vs. Creative Medical Technology (NASDAQ:CELZ)

Creative Medical Technology (NASDAQ:CELZ – Get Free Report) and Immunocore (NASDAQ:IMCR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Creative […] - 2025-04-01 02:57:01

Immunocore Holdings plc (NASDAQ:IMCR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have given a buy recommendation to the […] - 2025-03-26 04:56:59

Principal Financial Group Inc. Sells 43,461 Shares of Immunocore Holdings plc (NASDAQ:IMCR)

Principal Financial Group Inc. reduced its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 8.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 502,857 shares of the company’s stock after selling 43,461 shares during the period. Principal Financial […] - 2025-02-27 07:06:54

Immunocore Holdings plc (NASDAQ:IMCR) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating […] - 2025-02-04 06:36:58

Back to Listing

Disclaimer